BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 15017560)

  • 1. Biomolecular markers and involution of hemangiomas.
    Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature.
    Nasseri E; Piram M; McCuaig CC; Kokta V; Dubois J; Powell J
    J Am Acad Dermatol; 2014 Jan; 70(1):75-9. PubMed ID: 24176519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis.
    Chang J; Most D; Bresnick S; Mehrara B; Steinbrech DS; Reinisch J; Longaker MT; Turk AE
    Plast Reconstr Surg; 1999 Jan; 103(1):1-9; discussion 10. PubMed ID: 9915157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital hemangiomas.
    Boull C; Maguiness SM
    Semin Cutan Med Surg; 2016 Sep; 35(3):124-7. PubMed ID: 27607320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
    Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients.
    Zhang L; Lin X; Wang W; Zhuang X; Dong J; Qi Z; Hu Q
    Plast Reconstr Surg; 2005 Jul; 116(1):200-4. PubMed ID: 15988268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth.
    Przewratil P; Sitkiewicz A; Andrzejewska E
    Cytokine; 2010 Feb; 49(2):141-7. PubMed ID: 20015661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and extracellular markers of hemangioma.
    Tan ST; Velickovic M; Ruger BM; Davis PF
    Plast Reconstr Surg; 2000 Sep; 106(3):529-38. PubMed ID: 10987458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
    Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
    Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular markers that distinguish the phases of hemangioma during infancy and childhood.
    Takahashi K; Mulliken JB; Kozakewich HP; Rogers RA; Folkman J; Ezekowitz RA
    J Clin Invest; 1994 Jun; 93(6):2357-64. PubMed ID: 7911127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pigment epithelium-derived factor in the involution of hemangioma: autocrine growth inhibition of hemangioma-derived endothelial cells.
    Kim KJ; Yun JH; Heo JI; Lee EH; Min HS; Choi TH; Cho CH
    Biochem Biophys Res Commun; 2014 Nov; 454(2):282-8. PubMed ID: 25450390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly involuting congenital hemangioma with fetal involution.
    Maguiness S; Uihlein LC; Liang MG; Kozakewich H; Mulliken JB
    Pediatr Dermatol; 2015; 32(3):321-6. PubMed ID: 25492638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis and postnatal follow-up of rapidly involuting congenital hemangioma (RICH).
    Fadell MF; Jones BV; Adams DM
    Pediatr Radiol; 2011 Aug; 41(8):1057-60. PubMed ID: 21337126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.
    Calicchio ML; Collins T; Kozakewich HP
    Am J Pathol; 2009 May; 174(5):1638-49. PubMed ID: 19349369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas.
    North PE; Waner M; Mizeracki A; Mihm MC
    Hum Pathol; 2000 Jan; 31(1):11-22. PubMed ID: 10665907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of human hemangiosarcomas and hemangiomas.
    Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM
    Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W; Mikami T; Masuzawa M; Okayasu I
    Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous evolution patterns of focal congenital hepatic hemangiomas: a case series of 25 patients.
    Rutten C; Ladarre D; Ackermann O; Gonzales E; Guettier C; Franchi-Abella S
    Pediatr Radiol; 2022 May; 52(6):1048-1060. PubMed ID: 35229180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms tumor 1 expression in vascular neoplasms and vascular malformations.
    Trindade F; Tellechea O; Torrelo A; Requena L; Colmenero I
    Am J Dermatopathol; 2011 Aug; 33(6):569-72. PubMed ID: 21697701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly involuting congenital hemangioma (RICH): a brief case report.
    Scalise R; Bolton J; Gibbs NF
    Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.